Deletion of the A35 Gene from Modified Vaccinia Virus Ankara Increases Immunogenicity and Isotype Switching

Por Rehm, Kristina E., Roper, Rachel L.
Publicado em 2011

Physical activity levels and perceived benefits and barriers to physical activity in HIV-infected women living in the Deep South of the United States

Por Rehm, Kristina E., Konkle-Parker, Deborah
Publicado no AIDS Care (2016)

SARS vaccines: where are we?

Por Roper, Rachel L, Rehm, Kristina E
Publicado no Expert Rev Vaccines (2014)

Stress and Allergic Diseases

Por Dave, Ninabahen D., Xiang, Lianbin, Rehm, Kristina E., Marshall, Gailen D.
Publicado em 2011

Vaccinia Virus A35R Inhibits MHC Class II Antigen Presentation

Por Rehm, Kristina E., Connor, Ramsey F., Jones, Gwendolyn J.B., Yimbu, Kenneth, Roper, Rachel L.
Publicado em 2009

The Poxvirus A35 Protein Is an Immunoregulator

Por Rehm, Kristina E., Jones, Gwendolyn J. B., Tripp, Alice A., Metcalf, Mark W., Roper, Rachel L.
Publicado em 2010

Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II

Por Rehm, Kristina E, Connor, Ramsey F, Jones, Gwendolyn J B, Yimbu, Kenneth, Mannie, Mark D, Roper, Rachel L
Publicado em 2009